Chemical Structure (Amphetamine Er Orally 1)
Chemical structure of Amphetamine, showing the molecular formula C9H13N and molecular weight 135.21.*
Amphetamine Extended-release Tablet, Orally Disintegrating
Product Images NDC 62542-030
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amphetamine Extended-release (NDC 62542-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Neos Therapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Amphetamine Er Orally 2)
A pharmacokinetic line graph showing mean concentration (ng/mL) on the Y-axis versus time (hours) on the X-axis for dextramphetamine and levoamphetamine after administration of Amphetamine Extended-Release orally disintegrating tablets (XR-ODT) and MAS extended-release (ER) formulations. The graph compares concentration profiles over a 60-hour period.*
3.1 mg (Amphetamine Er Orally 3)
Packaging label for Amphetamine Extended-Release Orally Disintegrating Tablets, showing strength of 3.1 mg. The label includes warnings such as "NO COATING" and instructions to dispense the enclosed Medication Guide. The labeler is Neos Therapeutics, LP. The packaging references a 30 tablet count in a travel case and provides storage and handling details.*
6.3 mg (Amphetamine Er Orally 4)
Packaging label for Amphetamine Extended-Release Orally Disintegrating Tablets, 6.3 mg strength. The label indicates the product is a prescription drug supplied by Neos Therapeutics, LP. The carton design includes repeated mentions of the 6.3 mg dosage in teal circles and states that the tablets have no coating.*
9.4 mg (Amphetamine Er Orally 5)
The packaging label for Amphetamine Extended-Release Orally Disintegrating Tablets features prominently the 9.4 mg strength. The label states that the product is an orally disintegrating tablet with no coating. It includes NDC 62542-015-30 and highlights that the product is for prescription use only. The labeler is Neos Therapeutics, LP.*
12.5 mg (Amphetamine Er Orally 6)
Packaging label for Amphetamine Extended-Release orally disintegrating tablets, 12.5 mg strength. The label shows the product name, strength in yellow circles, NDC 62542-020-30, and indicates the product has no coating. The labeler is Neos Therapeutics, LP. The package contains 30 tablets as a 5x6-count blister tray in a travel case. The label includes handling and storage instructions and a barcode.*
15.7 mg (Amphetamine Er Orally 7)
Packaging label for Amphetamine Extended-Release 15.7 mg orally disintegrating tablets from Neos Therapeutics, LP. The label highlights the product strength in multiple purple circles and states 'NO COATING' prominently in red text. The design includes orange vertical bars with the NDC number 62542-025-30 and instructions to dispense the enclosed medication guide to each patient.*
18.8 mg (Amphetamine Er Orally 8)
Packaging label for Amphetamine Extended-Release orally disintegrating tablets, 18.8 mg strength, by Neos Therapeutics, LP. The label displays the product name and strength multiple times and includes warnings such as "NO COATING." It also shows NDC 62542-030-30 and indicates the product is prescription only (Rx Only). Additional text includes packaging and usage instructions, with a barcode at the bottom.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
